EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Roivant Sciences's enterprise value is €1,752.1 Mil.
Roivant Sciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was €115.4 Mil. Therefore, Roivant Sciences's EV-to-Revenue for today is 15.18.
The historical rank and industry rank for Roivant Sciences's EV-to-Revenue or its related term are showing as below:
FRA:87S'
s EV-to-Revenue Range Over the Past 10 Years
Min: 18.5 Med: 59.12 Max: 149.89
Current: 15.03
During the past 4 years, the highest EV-to-Revenue of Roivant Sciences was 149.89. The lowest was 18.50. And the median was 59.12.
FRA:87S's EV-to-Revenue is ranked worse than 62.6% of 1032
companies
in the Biotechnology industry
Industry Median: 7.65
vs FRA:87S: 15.03
As of today (2024-06-25), Roivant Sciences's stock price is €9.678.
Roivant Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was €0.14. Therefore, Roivant Sciences's PS Ratio for today is 68.15.
Roivant Sciences EV-to-Revenue Historical Data
The historical data trend for Roivant Sciences's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Roivant Sciences's EV-to-Revenue
For the Biotechnology subindustry, Roivant Sciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Roivant Sciences's EV-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Roivant Sciences's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Roivant Sciences's EV-to-Revenue falls into.
Roivant Sciences's current Enterprise Value is €1,752.1 Mil.
Roivant Sciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €115.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Roivant Sciences's share price for today is €9.678.
Roivant Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.14.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Roivant Sciences EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Roivant Sciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:87S has been successfully added to your 